By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Via della Posta 10

Bioggio    CH-6934  Switzerland
Phone: n/a Fax: n/a


Company News
Telormedix Granted European Patent For Vesimune 9/22/2014 11:49:18 AM
Telormedix' Vesimune Successfully Completes Phase 2 For Carcinoma In Situ Of The Bladder 5/16/2014 7:25:06 AM
Telormedix Raises $6.6 Million In Series B Financing Round 12/2/2013 10:40:38 AM
Molecular Profiles Selected to Develop Topical & Oral Psoriasis Products for Telormedix 9/23/2013 9:47:26 AM
Telormedix Receives EU Funding for the Development of a New Treatment for Psoriasis 8/7/2013 9:17:14 AM
Telormedix, Foamix Receive EU Funding for the Development of a New Topical Skin Cancer Treatment 6/4/2012 10:26:45 AM
Telormedix and SUPSI Receive Funding from CTI/KTI for Research Collaboration on Molecular Modeling of Drug-Target Interactions 3/6/2012 10:01:39 AM
Telormedix Elected Member of TIMER Collaborative Research Program 1/31/2012 9:00:10 AM
Telormedix Secures Further Funding With $7.5 Million CHF 1/10/2012 8:20:44 AM
Telormedix Announces Promising TMX-202 Preclinical Results for Skin Cancer Treatment 10/31/2011 9:13:42 AM